Before attempting to use social media for clinical trial subject recruitment and other drug development activities, designate a team to act on the issues and ideas that will likely come from the community you're accessing. In other words, look beyond your immediate objectives and be prepared to capitalize on what your constituency may teach you unintentionally.
This team should be part of the planning process for your social media strategy, says MediaPost, so members can become aware of the social environment and work through ideas of how to speak with the audience. For drugmakers, the team needs representation from regulatory affairs.
Actually, including multiple members from the regulatory group is an even better idea. Partnering with regulatory affairs can yield more paths to success while simultaneously preventing "a terse ‘no' to your plan at the 11th hour."
- see the article